Pediatric Hematology Unit - Ha'Emek Medical Center
Afula, 18101, Israel
NCT Number: NCT00736060
This study will summarized the clinical and laboratory data and the outcome of all the patients suffering from Sickle Cell Anemia (Including Sickle cell thalassemia) admitted to the pediatric ward.
Looking for future studies?
Notify MeAll sexes
Observational
Afula, 18101, Israel
The actual protocol for SCA patients admitted with fever is to obtain blood cultures and start empiric antibiotic treatment.
The study cohort included 60 SCA patients actually treated in the Pediatric Hematology Unit.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
All patients admitted with fever as the only presenting symptom.
Exclusion criteria
Patients admitted with another causes related or unrelated to sickle cell disease and have also fever.
Summary of clinical and laboratory data
HaEmek Medical Center, Israel
Other
Study the Clinical and Laboratory Characteristics and the Outcome of Sickle Cell Anemia Patients Admitted to the Pediatric Ward Because of Fever as the Presenting Symptom
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00512564
Anemia, Anemia, Hemolytic
Afula, Israel
View Trial DetailsNCT00512226
Anemia, Anemia, Hemolytic
Afula, Israel
View Trial DetailsNCT00480974
Anemia, Anemia, Hemolytic
Afula, Israel
View Trial DetailsNCT05675436
Anemia, Anemia, Hemolytic
Bethesda, Maryland, United States
View Trial Details